Applied StemCell Launches Hypoimmunogenic iPSC Tools to Accelerate Allogeneic Cell Therapy Development

Applied StemCell, a CRO/CDMO that blends unique genome editing technology and iPSC expertise, announced the launch of their first hypoimmunogenic hiPSC p...

May 21, 2025 | Wednesday | News
CellProthera Taps CELLforCURE by SEQENS to Manufacture First Clinical Batches of ProtheraCytes® by 2026

Manufacturing First clinical batches of ProtheraCytes® planned for 2026  CellProthera, a regenerative cell therapy developer specializing in isch...

May 21, 2025 | Wednesday | News
CellFE and Made Scientific Partner to Validate Scalable Non-Viral Gene Editing for T Cell Therapies

CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization...

May 14, 2025 | Wednesday | News
Azenta’s GENEWIZ and Form Bio Partner to Accelerate AAV Gene Therapy Development with Integrated Sequencing and AI Analysis

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. Azenta, Inc.a...

May 14, 2025 | Wednesday | News
PL BioScience and DewCell Introduce First Artificial Human Platelet Lysate Enabling Scalable Xeno-Free Cell Therapy Manufacturing

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceutical...

May 09, 2025 | Friday | News
Aspen Neuroscience Reports Positive 6-Month Data for ANPD001 in Parkinson’s Disease Ahead of IAPRD 2025 Presentation

ANPD001 was well tolerated with no major safety issues in low-dose cohort Patients showed early improvements in patient-reported and clinician-re...

May 08, 2025 | Thursday | News
Hovione and Firstgene Partner to Advance Precision Gene Therapy for Liver Cancer Using Novel AAV-Like Vector Platform

Exclusive licensing and R&D collaboration accelerate the development of a novel gene vector platform for precision gene therapy in Hepatocellular Car...

May 07, 2025 | Wednesday | News
Chengdu Origen and Vanotech Dose First Patient in Phase 1 Trial of KH658 Gene Therapy for Wet AMD

Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced  the first patient dosed ...

May 05, 2025 | Monday | News
Kytopen and Aldevron Partner to Streamline CRISPR T-Cell Engineering with Breakthrough Non-Viral Workflow

Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organ...

May 01, 2025 | Thursday | News
Innovent Biologics Doses First Patient in Global Phase 1 Trial of IBI3020, First-in-Class Dual-Payload CEACAM5 ADC

Innovent Biologics, Inc. ("Innovent"), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for t...

May 01, 2025 | Thursday | News
Accent Therapeutics Unveils Promising Preclinical Data on First-in-Class Cancer Therapeutics ATX-559 and ATX-295 at AACR 2025

 Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer therapeutics, announced new preclin...

April 29, 2025 | Tuesday | News
Carnegie Mellon Researchers 3D Print Living Tissue Models Entirely from Collagen

Collagen is well-known as an important component of skin, but its impact is much greater, as it is the most abundant protein in the body, providing structu...

April 25, 2025 | Friday | News
Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, PhD, MBA, Chief Operating Officer of Vector BioMed, shares how the company is reimagining...

April 25, 2025 | Friday | Interview
Capricorn Scientific and florabio Partner to Advance Animal-Free, High-Yield Cell Culture Solutions

Animal-free, high-yield solutions for scalable production Strategic partnership accelerating innovation from lab to GMP scale Breakthrough media for ...

April 21, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close